A NASH biotech plans $75M offering, Arrowhead nabs Amgen payment and Astria raises $115M

Terns Pharmaceuticals saw its stock $TERN climb 30% on Monday on the back of Madrigal Pharmaceuticals’ Phase III win in NASH — which itself likely entered the record books for a single-day stock $MDGL...

Click to view original post